Clinical Trials
7 trialsNCT00003129 2023-06-22
Chemotherapy in Treating Patients With Early-Stage Bladder Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT01438112 2021-04-14
BOND
CG Oncology, Inc.
Phase 2/3 Terminated
NCT01310803 2017-10-05
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder
Endo Pharmaceuticals
Phase 3 Terminated
NCT01606345 2016-04-22
Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT01316874 2015-06-12
Bladder Cancer
Endo Pharmaceuticals
Phase 2/3 Completed
NCT00003725 2013-11-06
Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003759 2013-01-31
AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer
National Cancer Institute (NCI)
Phase 2 Completed